Eneboparatide for treating chronic hypoparathyroidism [ID6532]
Awaiting development
Reference number: GID-TA11688
Expected publication date: TBC
Please note that this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during late September 2026. The deadline for submissions is expected in approximately late November 2026.